Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
BerGenBio
Biotech
BerGenBio, following lead drug's failure, merges with Oncoinvent
BerGenBio, reeling from the failure of its lead cancer drug, has opted to merge with fellow Norwegian cancer biotech Oncoinvent.
James Waldron
Jul 1, 2025 7:00am
Pfizer replaces retiring CSO with cancer chief—Chutes & Ladders
Nov 22, 2024 8:30am
BerGenBio shifts focus from COVID—to COVID in new strategy
May 5, 2022 10:57am
After phase 2 flop, BerGenBio posts new data on COVID prospect
Apr 26, 2022 2:26pm
BerGenBio fails COVID-19 trial, makes post hoc case for program
May 19, 2021 9:00am
BerGenBio posts updated data on trial of elderly AML patients
Jun 14, 2019 9:57am
